Veleva, Vesela; W. Cue Jr, Berkeley - In: Benchmarking: An International Journal 24 (2017) 5, pp. 1414-1436
/methodology/approach The authors examined publicly available data for the top 10 “big pharma” and top ten generic drug manufacturers. Using the …/implications The research is based on publicly disclosed information. It is possible that some generic drug manufacturers have begun to … generic drug manufacturers. Practical implications The company-level analysis, benchmarking framework and results are of value …